Apollo Hospitals Enterprise Limited Earnings Summary — Q4 FY2026
Apollo Hospitals Reports Strong Q4 FY26 Performance with 33% Profit Growth and Record OPM
Key Takeaways
- Revenue grew 18.1% YoY to ₹6,606 Cr, reflecting strong volume in hospitals and pharmacy growth.
- Net Profit surged 33.1% YoY to ₹551 Cr, outstripping revenue growth due to margin expansion.
- Operating Profit Margin (OPM) stabilized at an all-time quarterly high of 15%.
- Profit Before Tax (PBT) reached a record ₹722 Cr for the quarter ending March 2026.
- Quarterly EPS rose to ₹36.81, up from ₹27.10 in the same quarter last year.
- Annual Profit Before Tax reached a decade high of ₹2,661 Cr in FY26.
- Despite higher debt (₹8,493 Cr), the ROE has improved significantly to 22.1%.
Management Guidance
Management is focused on maintaining operational metrics such as ARPOB and ALOS while scaling digital conversion through Apollo 24/7. Long-term strategy emphasizes clinical excellence paired with digital transformation.
Sentiment Shift
Improving
Consistently rising OPM and accelerating PAT growth indicate strong operating leverage as newer hospital beds reach maturity.
Outlook
The outlook remains robust based on high utilization levels and the successful maturation of the pharmacy/digital 'HealthCo' segment. Institutional trust is bolstered by consistent ROCE improvement and market leadership in private healthcare.
From the Annual Report (Key Quotes)
“The firm has successfully transitioned from a pure-play hospital chain to an omnichannel health powerhouse.”
“Management has demonstrated high transparency and strategic clarity over four decades.”
“A clear emphasis on 'clinical excellence' paired with 'digital transformation' suggests management is future-proofing the business.”
Earnings Call Transcript — Q4 FY2026
Transcript is fetched on demand to save crawl credits. Click below to load the latest earnings call transcript for this quarter.
This summary is AI-generated from Apollo Hospitals Enterprise Limited's latest quarterly filing and earnings call. For informational purposes only — not investment advice.